TORCH and Special ID Assays
Siemens Healthineers provides TORCH and special infectious-disease assays for improved prenatal and specialty care.

TORCH and Special ID Assays
Contact Us

Siemens Healthineers provides TORCH and Special ID testing solutions for diagnostic laboratories with a comprehensive assay menu on the ADVIA Centaur® Immunoassay Systems and IMMULITE® Systems.*

 ADVIA Centaur® SystemsAtellica® SolutionIMMULITE® Systems
CMV IgG                 √*      √*       √
CMV IgM                 √*      √*       √
EBV-EBNA IgG       √*       √§,**
EBV-VCA IgG       √*       √§,**
EBV-VCA IgM       √*       √§,**
Herpes-1 IgG                √§      √* 
Herpes-2 IgG                √§      √* 
Herpes I and II IgG         √
H. pylori IgG         √
Rubella IgG                √       √ 
Rubella IgM                √       √       √
Rubella Quantitative IgG         √
Syphilis                √      √       √**
Toxoplasma IgG                √      √       √
Toxoplasma IgM                √††      √ 
Toxoplasma Quantitative IgG         √
Zika Test                √*  


*Under development. Not commercially available. Future availability cannot be guaranteed.
§ Not available for sale in the U.S.
** Not available on IMMULITE 1000
++ In development on ADVIA Centaur CP

The products featured here may not be commercially available in all countries. Due to regulatory restrictions, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers representative for further details

Share this page:

Related Products, Services & Resources

*System and assay availability is subject to local regulatory requirements.
Under development. Not available for sale.
Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.
§Not available on IMMULITE 1000.
**In development on ADVIA Centaur CP.
††The ADVIA Centaur Zika Test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories, only for the diagnosis for Zika virus infection and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.